References
- Keçecioğlu M, Tokmak A, Keçecioğlu TS, et al. Does progesterone therapy increase nuchal translucency in women with threatened miscarriage? Ginekol Pol. 2016;87:390–394.
- Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004;190:745–750.
- Simpson JL, Mills JL, Holmes LB, et al. Low fetal loss rates after ultrasound-proved viability in early pregnancy. JAMA. 1987;258:2555–2557.
- Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69:1–7.
- McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem. 1993;26:351–357.
- Favier A. Oxidative stress in human diseases. Ann Pharm Fr. 2006;64:390–396.
- Gergerlioglu HS, Savas HA, Bulbul F, et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog NeuroPsychopharmacol Biol Psychiatry. 2007;31:697–702.
- Poston L, Raijmakers MT. Trophoblast oxidative stress, antioxidants and pregnancy outcome - a review. Placenta. 2004;25:S72–S78.
- Gupta S, Agarwal A, Banerjee J, et al. The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv. 2007;62:335–347.
- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326–332.
- Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601–623.
- Gubaljevic JG, Causevic A. Monitoring changes in serum 8-isoprostane concentration as a possible marker of oxidative stress in pregnancy. J Health Sci. 2013;3:227–231.
- Hempstock J, Jauniaux E, Greenwold N, et al. The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol. 2003;34:1265–1275.
- Deveer R, Deveer M, Engin-Üstün Y, et al. Role of oxidative stress on vaginal bleeding during the first trimester of pregnant women. Int J Fertil Steril. 2014;7:271–274.
- Vural P, Akgül C, Yildirim A, et al. Antioxidant defence in recurrent abortion. Clin Chim Acta. 2000;295:169–177.
- Yiyenoğlu ÖB, Uğur MG, Özcan HÇ, et al. Assessment of oxidative stress markers in recurrent pregnancy loss: a prospective study. Arch Gynecol Obstet. 2014;289:1337–1340.
- Ozkaya O, Sezik M, Kaya H. Serum malondialdehyde, erythrocyte glutathione peroxidase, and erythrocyte superoxide dismutase levels in women with early spontaneous abortions accompanied by vaginal bleeding. Med Sci Monit. 2008;14:CR47–CR51.
- Toy H, Camuzcuoglu H, Camuzcuoglu A, et al. Decreased serum prolidase activity and increased oxidative stress in early pregnancy loss. Gynecol Obstet Invest. 2010;69:122–127.
- Janaszewska A, Bartosz G. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest. 2002;62:231–236.
- Korkmaz V, Kurdoglu Z, Alisik M, et al. Impairment of thiol-disulfide homeostasis in preeclampsia. J Matern Fetal Neonatal Med. 2016;29:3848–3853.
- Andriollo-Sanchez M, Hininger-Favier I, Meunier N, et al. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr. 2005;59:S58–S62.
- Ozler S, Oztas E, Caglar AT, et al. Thiol/disulfide homeostasis in predicting adverse perinatal outcomes at 24–28 weeks of pregnancy in gestational diabetes. J Matern Fetal Neonatal Med. 2016;29:3699–3704.
- Ozler S, Oztas E, Tokmak A, et al. The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016;84:516–523.
- Isik H, Sahbaz A, Timur H, et al. The use of thiol/disulfide as a novel marker in premature ovarian failure. Gynecol Obstet Invest. 2017;82:113–118.